China Issues Ethical Guidelines for Human Genome Editing, Prohibits Germline Editing
China’s Ministry of Science and Technology (MOST) has issued the Ethical Guidelines for Human Genome...
Biotech
CR Boya Bio-Pharmaceutical’s Strategic Foray: Acquiring Green Cross HK for $250M to Expand Biopharma Dominance
In a significant development for the biopharmaceutical industry, China Resources Medical Holdings Company Limited and...
Jiangsu Hengrui Pharmaceuticals Faces FDA Setback with Warning Letter for Quality Control Issues
Jiangsu Hengrui Pharmaceuticals (SHA: 600276), a prominent player in China’s pharmaceutical industry, has received a...
Legend Biotech’s Shares Leap on Acquisition Rumors; Parent Genscript Biotech Corp. Follows Suit
Chinese biopharmaceutical firm Legend Biotech (NASDAQ: LEGN), a specialist in chimeric antigen receptor (CAR) T-cell...
Quantum Hi-Tech Partners with East China Normal University to Establish Advanced Drug Research Lab
Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), has entered into a...
Tracon Pharmaceuticals Halts Development of Envafolimab After Clinical Trial Failure
Tracon Pharmaceuticals (OTCMKTS: TCON), a US-based biopharmaceutical company, has decided to cease development of its...
Healthcare Firms Line Up for HKEX IPOs as Biotech Market Recovery Gains Momentum
A number of healthcare companies are seeking to capitalize on the recovering market conditions by...
Hasten Biopharmaceutical Expands into Pan-Asia Regions with Celltrion Asset Acquisition
Hasten Biopharmaceutical Co., Ltd, a China-based pharmaceutical company backed by CBC Group, has announced an...
Aidea Pharmaceutical to Boost Stake in Nanda Pharmaceutical to 51.1256%
Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488), a pharmaceutical company based in China, is poised...
Jiangsu Jibeier Pharm Completes Private Placement to Fund R&D Center on STAR Market
Jiangsu Jibeier Pharm Co., Ltd (SHA: 688566), a Chinese pharmaceutical company, has announced the successful...
Fosun Pharma to Take Henlius Private in Deal Valued at HKD 5.407 Billion
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced plans to take...
Ascentage Pharma’s THDBH120 Receives NMPA Approval for Phase Ib Clinical Trial
Ascentage Pharma (HKG: 6855), a biopharmaceutical company based in China, has announced that it has...
Shanghai Fosun Pharmaceutical Sells Stake in Gland Pharma for USD 211 Million
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced the sale of...
Jiuzhou Pharmaceutical Shuts Down Two Subsidiaries to Streamline Operations
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA: 603456), a pharmaceutical company based in China, has announced...
Grifols Completes Sale of 20% Stake in Shanghai RAAS to Haier Group for RMB 12.5 Billion
Grifols AS (NASDAQ: GRFS), a Spain-based global leader in the production of blood products, has...
3SBio Secures Long-Term Financing from IFC for Manufacturing and Global Expansion
3SBio Inc. (HKG: 1530), a biopharmaceutical company based in China, is slated to receive long-term...
Takeda Secures Global Rights to Ascentage Pharma’s Olverembatinib Outside of China and Select Territories
Takeda Pharmaceuticals, a leading biopharmaceutical company based in Japan (TYO: 4502), has entered into an...
Sihuan’s Xuanzhu Biopharmaceutical Strikes Licensing Deal with Livzon Pharmaceutical for Fadanafil
Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has declared that its subsidiary, Xuanzhu Biopharmaceutical Co.,...
CStone Pharmaceuticals Gets NMPA Green Light for Local Production of Gavreto
CStone Pharmaceuticals (HKG: 2616), a leading biopharmaceutical company based in China, has announced that it...
Apeloa Pharmaceutical Partners with Beijing Highthink for CRO Services on Semaglutide Generic
Apeloa Pharmaceutical Co., Ltd (SHE: 000739), a China-based pharmaceutical company, has forged a strategic partnership...